Payment overview · 2025
General Payments
$555.92
25 reported records · 10 companies
Healthcare provider profile · identity verified
Michael Holger Albert, MD
Allopathic & Osteopathic Physicians|Family Medicine · RICHLAND, MS · NPI 1679562094
Verified facts
What the public records show
CMS Open Payments records show Michael Holger Albert, MD received $555.92 in general payments during 2025 across 25 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 29.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 81 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Synthroid by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 70 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rybelsus by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Tresiba as an associated drug or biological on 415 records involving 264 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Tresiba by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 255 claims for Nuedexta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 2243 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $162.08 | 29.2% | 8 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $141.05 | 25.4% | 7 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $60.13 | 10.8% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $44.45 | 8.0% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $33.73 | 6.1% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $32.18 | 5.8% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $25.98 | 4.7% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.26 | 3.5% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $19.26 | 3.5% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $17.80 | 3.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $555.92 | 25 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $195.81 | 9 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $141.05 | 7 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $60.13 | 2 | 2025 |
Source payment records
|
|||||
| DALVANCE Normalized: dalvance |
Drug | ABBVIE INC. | $44.45 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32.18 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $25.98 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $19.26 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $19.26 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $19.26 | 1 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc. | $17.80 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc. | $17.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 70 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
81 | 20 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
48 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
70 | 18 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Tresiba open payments reported associated product |
CMS Open Payments — General Payments 415 supporting records · 264 recipient NPIs · example record 1188130328 |
Tresiba · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
255 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
54 | 54 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2243 | 121 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 4929 | 321 |
| Amlodipine Besylate | Amlodipine Besylate | 3050 | 241 |
| Sertraline Hcl | Sertraline Hcl | 2603 | 165 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2601 | 226 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2585 | 198 |
| Gabapentin | Gabapentin | 2325 | 186 |
| Eliquis | Apixaban | 2243 | 121 |
| Memantine Hcl | Memantine Hcl | 2105 | 116 |
| Potassium Chloride | Potassium Chloride | 2026 | 163 |
| Furosemide | Furosemide | 1986 | 188 |
| Divalproex Sodium | Divalproex Sodium | 1745 | 96 |
| Losartan Potassium | Losartan Potassium | 1690 | 133 |
| Donepezil Hcl | Donepezil Hcl | 1611 | 105 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1534 | 129 |
| Carvedilol | Carvedilol | 1445 | 120 |
| Quetiapine Fumarate | Quetiapine Fumarate | 1361 | 110 |
| Lisinopril | Lisinopril | 1346 | 90 |
| Famotidine | Famotidine | 1320 | 87 |
| Mirtazapine | Mirtazapine | 1273 | 106 |
| Metformin Hcl | Metformin Hcl | 1264 | 103 |
| Olanzapine | Olanzapine | 1257 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 1160 | 94 |
| Trazodone Hcl | Trazodone Hcl | 1136 | 110 |
| Levetiracetam | Levetiracetam | 1081 | 77 |
| Omeprazole | Omeprazole | 1081 | 113 |
| Pravastatin Sodium | Pravastatin Sodium | 1075 | 71 |
| Duloxetine Hcl | Duloxetine Hcl | 1046 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1034 | 96 |
| Clopidogrel | Clopidogrel Bisulfate | 1009 | 96 |
| Buspirone Hcl | Buspirone Hcl | 979 | 81 |
| Citalopram Hbr | Citalopram Hydrobromide | 732 | 54 |
| Aripiprazole | Aripiprazole | 609 | 29 |
| Meloxicam | Meloxicam | 602 | 46 |
| Montelukast Sodium | Montelukast Sodium | 593 | 46 |
| Escitalopram Oxalate | Escitalopram Oxalate | 589 | 56 |
| Baclofen | Baclofen | 586 | 41 |
| Risperidone | Risperidone | 551 | 49 |
| Spironolactone | Spironolactone | 537 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 516 | 51 |
| Hydralazine Hcl | Hydralazine Hcl | 514 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 480 | 58 |
| Divalproex Sodium Er | Divalproex Sodium | 476 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 447 | 32 |
| Nifedipine Er | Nifedipine | 396 | 32 |
| Finasteride | Finasteride | 382 | 31 |
| Entresto | Sacubitril/Valsartan | 381 | 25 |
| Xarelto | Rivaroxaban | 320 | 22 |
| Allopurinol | Allopurinol | 313 | 37 |
| Januvia | Sitagliptin Phosphate | 312 | 18 |
| Topiramate | Topiramate | 309 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 300 | 28 |
| Myrbetriq | Mirabegron | 295 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 286 | 23 |
| Doxepin Hcl | Doxepin Hcl | 283 | 19 |
| Farxiga | Dapagliflozin Propanediol | 280 | 23 |
| Jardiance | Empagliflozin | 276 | 25 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 274 | 19 |
| Simvastatin | Simvastatin | 262 | 27 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 255 | suppressed |
| Prednisone | Prednisone | 247 | 68 |
| Benztropine Mesylate | Benztropine Mesylate | 246 | 26 |
| Haloperidol | Haloperidol | 246 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 245 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 236 | 90 |
| Ezetimibe | Ezetimibe | 236 | 18 |
| Sucralfate | Sucralfate | 235 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 226 | 100 |
| Terazosin Hcl | Terazosin Hcl | 210 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 209 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 205 | 99 |
| Sevelamer Carbonate | Sevelamer Carbonate | 205 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 203 | 14 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 198 | 36 |
| Azithromycin | Azithromycin | 192 | 137 |
| Rivastigmine | Rivastigmine Tartrate | 191 | 11 |
| Glimepiride | Glimepiride | 190 | 22 |
| Metformin Hcl Er | Metformin Hcl | 190 | 11 |
| Oxcarbazepine | Oxcarbazepine | 188 | 14 |
| Clonidine Hcl | Clonidine Hcl | 187 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 186 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 181 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 174 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 171 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 165 | 16 |
| Lamotrigine | Lamotrigine | 165 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 162 | 12 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 162 | suppressed |
| Primidone | Primidone | 159 | 11 |
| Tradjenta | Linagliptin | 157 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 152 | 11 |
| Valsartan | Valsartan | 152 | 18 |
| Paliperidone Er | Paliperidone | 149 | suppressed |
| Torsemide | Torsemide | 149 | suppressed |
| Latanoprost | Latanoprost | 147 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 141 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 140 | 27 |
| Alendronate Sodium | Alendronate Sodium | 138 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 138 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 136 | 12 |
| Chlorthalidone | Chlorthalidone | 132 | suppressed |
| Lovastatin | Lovastatin | 132 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 128 | 26 |
| Lubiprostone | Lubiprostone | 128 | suppressed |
| Bupropion Xl | Bupropion Hcl | 127 | 14 |
| Fenofibrate | Fenofibrate | 127 | 11 |
| Midodrine Hcl | Midodrine Hcl | 124 | 14 |
| Meclizine Hcl | Meclizine Hcl | 119 | 21 |
| Amantadine | Amantadine Hcl | 116 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 115 | 53 |
| Colchicine | Colchicine | 112 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 110 | 63 |
| Metoclopramide Hcl | Metoclopramide Hcl | 108 | 11 |
| Glipizide | Glipizide | 107 | suppressed |
| Glipizide Er | Glipizide | 105 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 104 | 23 |
| Pregabalin | Pregabalin | 102 | 27 |
| Carbamazepine | Carbamazepine | 98 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 98 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 97 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 97 | 66 |
| Methocarbamol | Methocarbamol | 97 | 28 |
| Tramadol Hcl | Tramadol Hcl | 95 | 45 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 92 | 71 |
| Ibuprofen | Ibuprofen | 91 | 23 |
| Atenolol | Atenolol | 88 | 14 |
| Benazepril Hcl | Benazepril Hcl | 87 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 87 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 86 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 83 | 25 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 83 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 83 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 82 | 45 |
| Lactulose | Lactulose | 82 | 33 |
| Linzess | Linaclotide | 81 | 20 |
| Nystatin | Nystatin | 81 | 45 |
| Fenofibrate | Fenofibrate Nanocrystallized | 80 | 17 |
| Fluconazole | Fluconazole | 80 | 57 |
| Insulin Aspart Flexpen | Insulin Aspart | 78 | 19 |
| Lorazepam | Lorazepam | 76 | 31 |
| Ziprasidone Hcl | Ziprasidone Hcl | 76 | suppressed |
| Levofloxacin | Levofloxacin | 75 | 60 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 75 | 19 |
| Clindamycin Hcl | Clindamycin Hcl | 72 | 52 |
| Novolin R | Insulin Regular, Human | 71 | 18 |
| Novolog Flexpen | Insulin Aspart | 71 | 23 |
| Clonazepam | Clonazepam | 70 | 28 |
| Ozempic | Semaglutide | 70 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 69 | suppressed |
| Metolazone | Metolazone | 69 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 69 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 69 | suppressed |
| Ranolazine Er | Ranolazine | 67 | suppressed |
| Trulicity | Dulaglutide | 67 | suppressed |
| Lansoprazole | Lansoprazole | 66 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 41 |
| Bupropion Hcl Sr | Bupropion Hcl | 64 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 63 | suppressed |
| Brilinta | Ticagrelor | 61 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 60 | 11 |
| Insulin Lispro | Insulin Lispro | 60 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 60 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 50 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 58 | 25 |
| Levemir Flexpen | Insulin Detemir | 58 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 58 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 57 | suppressed |
| Estradiol | Estradiol | 56 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 56 | 17 |
| Restasis | Cyclosporine | 55 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 54 | 54 |
| Rivastigmine | Rivastigmine | 54 | 21 |
| Mupirocin | Mupirocin | 53 | 42 |
| Promethazine Hcl | Promethazine Hcl | 53 | 20 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 53 | 15 |
| Leucovorin Calcium | Leucovorin Calcium | 52 | suppressed |
| Dutasteride | Dutasteride | 51 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 51 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 48 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 48 | suppressed |
| Lacosamide | Lacosamide | 48 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 48 | 38 |
| Synthroid | Levothyroxine Sodium | 48 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 46 | 14 |
| Isosorbide Dinit-Hydralazine | Isosorbide Dinit/Hydralazine | 46 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 45 | 38 |
| Cephalexin | Cephalexin | 45 | 41 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 43 | suppressed |
| Novolog | Insulin Aspart | 43 | 11 |
| Digoxin | Digoxin | 42 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 42 | suppressed |
| Naproxen | Naproxen | 41 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 41 | suppressed |
| Gemtesa | Vibegron | 40 | suppressed |
| Calcitriol | Calcitriol | 39 | suppressed |
| Cefdinir | Cefdinir | 39 | 25 |
| Albuterol Sulfate | Albuterol Sulfate | 38 | 20 |
| Alprazolam | Alprazolam | 38 | 19 |
| Amoxicillin | Amoxicillin | 38 | 33 |
| Enalapril Maleate | Enalapril Maleate | 38 | suppressed |
| Ketoconazole | Ketoconazole | 37 | 29 |
| Novolin N | Insulin Nph Human Isophane | 37 | suppressed |
| Entacapone | Entacapone | 36 | suppressed |
| Nystop | Nystatin | 36 | 24 |
| Symbicort | Budesonide/Formoterol Fumarate | 36 | suppressed |
| Auryxia | Ferric Citrate | 35 | suppressed |
| Ondansetron Odt | Ondansetron | 35 | 24 |
| Prednisolone Acetate | Prednisolone Acetate | 35 | 16 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 35 | suppressed |
| Benlysta | Belimumab | 34 | suppressed |
| Humulin R | Insulin Regular, Human | 34 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 33 | 33 |
| Incruse Ellipta | Umeclidinium Bromide | 33 | 11 |
| Sevelamer Hcl | Sevelamer Hcl | 33 | suppressed |
| Timolol Maleate | Timolol Maleate | 33 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 32 | suppressed |
| Cilostazol | Cilostazol | 31 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 31 | 16 |
| Scopolamine | Scopolamine | 31 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 11 |
| Xifaxan | Rifaximin | 31 | suppressed |
| Clonidine | Clonidine | 30 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 30 | suppressed |
| Levemir | Insulin Detemir | 30 | 11 |
| Celecoxib | Celecoxib | 29 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 29 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 29 | suppressed |
| Insulin Aspart | Insulin Aspart | 29 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 29 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 28 | suppressed |
| Semglee (Yfgn) | Insulin Glargine-Yfgn | 28 | 14 |
| Humalog | Insulin Lispro | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | 13 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 26 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 26 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 26 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 25 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 25 | suppressed |
| Zonisamide | Zonisamide | 25 | suppressed |
| Budesonide | Budesonide | 24 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 24 | 17 |
| Lithium Carbonate | Lithium Carbonate | 24 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 23 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 23 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | 13 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 22 | suppressed |
| Clozapine | Clozapine | 22 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 22 | suppressed |
| Easy Touch Safety Pen Needle | Pen Needle, Diabetic, Safety | 22 | 15 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | suppressed |
| Permethrin | Permethrin | 22 | 13 |
| Probenecid | Probenecid | 22 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 21 | 19 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 21 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 21 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Carbamazepine Er | Carbamazepine | 20 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 20 | suppressed |
| Sotalol | Sotalol Hcl | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Travoprost | Travoprost | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 16 |
| Renvela | Sevelamer Carbonate | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | 14 |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | 11 |
| Calcium Acetate | Calcium Acetate | 18 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 18 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 18 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 18 | suppressed |
| Anastrozole | Anastrozole | 17 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 17 | 17 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Meropenem | Meropenem | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 17 | suppressed |
| Phenytoin | Phenytoin | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Erythromycin | Erythromycin Base | 16 | 13 |
| Lidocaine | Lidocaine | 16 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 16 | 15 |
| Nitroglycerin | Nitroglycerin | 16 | 15 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Cyclosporine | Cyclosporine | 15 | suppressed |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 14 |
| Tresiba | Insulin Degludec | 15 | suppressed |
| Trospium Chloride | Trospium Chloride | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 14 | 14 |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Ciclopirox | Ciclopirox | 13 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Phenazopyridine Hcl | Phenazopyridine Hcl | 13 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $555.92 · 25 records | Otsuka America Pharmaceutical, Inc. | AUSTEDO XR, CAPLYTA, CT THROMBECTOMY SYSTEM KIT, DALVANCE, FLOWTRIEVER CATHETER, S, INGREZZA, Kerendia, Ozempic, PAXLOVID, REXULTI, Rybelsus | 10 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error